Behavioral Interventions to Reduce Alcohol Use Among Patients with Hepatitis C: A Systematic Review

被引：11

作者：

Sims, Omar T. ^{[1
,2
,3
,4
]}

Maynard, Quentin R. ^{[5
]}

Melton, Pam A. ^{[5
,6
]}

机构：

[1] Univ Alabama Birmingham, Dept Social Work, Coll Arts & Sci, HB 301C1,17 2nd Ave S, Birmingham, AL 35294 USA

[2] Univ Alabama Birmingham, Sch Publ Hlth, Dept Hlth Behav, Birmingham, AL 35294 USA

[3] Univ Alabama Birmingham, Ctr AIDS Res, Birmingham, AL USA

[4] Univ Alabama Birmingham, Ctr Comprehens Hlth Aging, Birmingham, AL USA

[5] Univ Alabama, Sch Social Work, Tuscaloosa, AL USA

[6] Tulane Univ, Sch Social Work, New Orleans, LA 70118 USA

来源：

SOCIAL WORK IN PUBLIC HEALTH | 2016年 / 31卷 / 06期

关键词：

Hepatitis C; liver disease; treatment; medical and clinical social workers; RANDOMIZED CONTROLLED-TRIAL; MOTIVATIONAL ENHANCEMENT THERAPY; VIRUS-INFECTION; CLINICAL-TRIALS; SOCIAL SUPPORT; USE DISORDERS; INJECT DRUGS; RISK; RIBAVIRIN; HEALTH;

D O I：

10.1080/19371918.2016.1160346

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Alcohol use is a barrier to pharmacologic treatment for hepatitis C virus (HCV). It is advantageous for medical and clinical social workers engaged in HCV care to be knowledgeable of behavioral interventions that can be used to reduce alcohol use among patients with HCV. This article identifies and describes studies that designed and implemented behavioral interventions to reduce alcohol use among patients with HCV in clinical settings. To achieve this goal, this article conducts a rigorous systematic review to identify peer-reviewed articles, describes each behavioral intervention, and reports primary outcomes of each study included in the review.

引用

页码：565 / 573

页数：9

共 46 条

[1] A low-cost, sustainable intervention for drinking reduction in the HIV primary care setting
Aharonovich, E.
Hatzenbuehler, M. L.
Johnston, B.
O'Leary, A.
Morgenstern, J.
Wainberg, M. L.
Yao, P.
Helzer, J. E.
Hasin, D. S.
[J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2006, 18 (06): : 561 - 568
[2] Safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: Analysis of phase III ION trials
Alqahtani, Saleh A.
Afdhal, Nezam
Zeuzem, Stefan
Gordon, Stuart C.
Mangia, Alessandra
Kwo, Paul
Fried, Michael
Yang, Jenny C.
Ding, Xiao
Pang, Phillip S.
McHutchison, John G.
Pound, David
Reddy, K. Rajender
Marcellin, Patrick
Kowdley, Kris V.
Sulkowski, Mark
[J]. HEPATOLOGY, 2015, 62 (01) : 25 - 30
[3] [Anonymous], 2002, STRUCTURED CLIN INTE
[4] [Anonymous], COMMUNICATION
[5] Eligibility of persons who inject drugs for treatment of hepatitis C virus infection
Arain, Amber
Robaeys, Geert
[J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (36) : 12722 - 12733
[6] Mental and physical symptoms associated with lower social support for patients with hepatitis C
Blasiole, Julie A.
Shinkunas, Laura
LaBrecque, Douglas R.
Arnold, Robert M.
Zickmund, Susan L.
[J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (29) : 4665 - 4672
[7] Interventions to Reduce Alcohol Use among HIV-Infected Individuals: A Review and Critique of the Literature
Brown, Jennifer L.
DeMartini, Kelly S.
Sales, JessicaM.
Swartzendruber, Andrea L.
DiClemente, Ralph J.
[J]. CURRENT HIV/AIDS REPORTS, 2013, 10 (04) : 356 - 370
[8] Hepatitis C virus infection in USA: an estimate of true prevalence
Chak, Eric
Talal, Andrew H.
Sherman, Kenneth E.
Schiff, Eugene R.
Saab, Sammy
[J]. LIVER INTERNATIONAL, 2011, 31 (08) : 1090 - 1101
[9] Efficacy of motivational enhancement therapy on alcohol use disorders in patients with chronic hepatitis C: a randomized controlled trial
Dieperink, Eric
Fuller, Bret
Isenhart, Carl
McMaken, Kelly
Lenox, Rebecca
Pocha, Christine
Thuras, Paul
Hauser, Peter
[J]. ADDICTION, 2014, 109 (11) : 1869 - 1877
[10] Dieperink E, 2010, PSYCHOSOMATICS, V51, P149, DOI 10.1176/appi.psy.51.2.149

← 1 2 3 4 5 →